Korean J Med.
2019 Feb;94(1):17-39. 10.3904/kjm.2019.94.1.17.
2018 KHRS Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Korean Patients with Atrial Fibrillation: How to Initiate and Organize the Follow-up
- Affiliations
-
- 1Department of Cardiology, Hanyang University Seoul Hospital, Seoul, Korea.
- 2Department of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. djunkim@gmail.com
- 3Department of Cardiology, Inha University Hospital, Incheon, Korea.
- 4Department of Cardiology, Soon Chun Hyang University Hospital, Seoul, Korea.
- 5Department of Cardiology, The Catholic University of Korea St. Vincent's Hospital, Suwon, Korea.
- 6Division of Cardiology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
- 7Department of Cardiology, Chungbuk National University College of Medicine, Chungju, Korea.
- 8Department of Cardiology, Chonnam National University Hospital, Chonnam National University Medical School, Gwangju, Korea.
- 9Department of Cardiology, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea.
- KMID: 2438026
- DOI: http://doi.org/10.3904/kjm.2019.94.1.17
Abstract
- Non-vitamin K antagonist oral anticoagulants (NOACs) are alternatives to vitamin K antagonists to prevent stroke in patients with non-valvular atrial fibrillation (AF) and have emerged as the preferred choice. The use of NOACs is rapidly increasing in Korea after coverage by insurance since 2015. However, the rate of prescribing anticoagulants in Korean patients with AF remains low compared to other countries. Most of the NOAC anticoagulant prescriptions are issued at hospitals. As the prevalence rate of AF in Korea is expected to increase rapidly with the increase in the elderly population, the need to prescribe NOACs in primary care clinics will also increase. Therefore, The Korean Heart Rhythm Society organized the Korean Atrial Fibrillation Management Guideline Committee and analyzed all available studies based on the 2018 European Heart Rhythm Association Practical Guide on the use of NOACs for managing AF, as well as studies on Korean patients. The authors would like to introduce practical guidelines for NOAC prescriptions in Korean patients with AF.
